Ahmed Al-Ogaili

Ahmed Al-Ogaili, MD

Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellow

The Minneapolis Heart Institute Foundation Center for Coronary Artery Disease welcomes Ahmed Al-Ogaili, MD, as the Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellow as of July 1, 2023.

Dr. Al-Ogaili joins MHIF from Rush University Medical Center, Chicago, where he completed his training in interventional cardiology. He obtained his medical degree from Jordan University of Science and Technology in Jordan. Subsequently, Dr. Al-Ogaili moved to the United States and completed his Internal Medicine residency and Cardiovascular Disease fellowship at Cook County Hospital in Chicago. During his training he served as a Chief medical resident and Chief cardiology fellow and won multiple clinical excellence awards.

Throughout his medical training, Dr. Al-Ogaili has been actively involved in research, with presentations at the major cardiology congresses and peer-reviewed publications. He is Board Certified in Internal Medicine, Nuclear Cardiology, Echocardiography, Cardiac CT, and cardiovascular diseases.

Back to Coronary Team

Ahmed Al-Ogaili
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute FoundationĀ® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.